Integra LifeSciences Holdings Corporation Stock
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.9 USD | +0.32% | +9.15% | -29.05% |
Financials (USD)
Sales 2024 * | 1.68B | Sales 2025 * | 1.77B | Capitalization | 2.43B |
---|---|---|---|---|---|
Net income 2024 * | 95M | Net income 2025 * | 157M | EV / Sales 2024 * | 2.22 x |
Net Debt 2024 * | 1.29B | Net Debt 2025 * | 1.44B | EV / Sales 2025 * | 2.19 x |
P/E ratio 2024 * |
27.1
x | P/E ratio 2025 * |
16.7
x | Employees | 3,946 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.08% |
Latest transcript on Integra LifeSciences Holdings Corporation
1 day | +0.32% | ||
1 week | +9.15% | ||
1 month | +5.93% | ||
3 months | -16.28% | ||
6 months | -21.15% | ||
Current year | -29.05% |
Managers | Title | Age | Since |
---|---|---|---|
Jan de Witte
CEO | Chief Executive Officer | 59 | 21-11-30 |
Lea Knight
DFI | Director of Finance/CFO | 52 | 23-06-27 |
Stuart Essig
CHM | Chairman | 62 | 97-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Graves
BRD | Director/Board Member | 62 | Dec. 11 |
Stuart Essig
CHM | Chairman | 62 | 97-11-30 |
Christian Schade
BRD | Director/Board Member | 63 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.75% | 2 M€ | -.--% | ||
0.71% | 8 M€ | -.--% | ||
0.20% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 30.9 | +0.32% | 1,257,475 |
24-05-30 | 30.8 | +4.05% | 1,293,741 |
24-05-29 | 29.6 | +2.53% | 1,121,623 |
24-05-28 | 28.87 | +1.98% | 986,548 |
24-05-24 | 28.31 | -0.70% | 814,733 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.05% | 2.43B | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- IART Stock